2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …

PA Heidenreich, B Bozkurt, D Aguilar, LA Allen… - Journal of the American …, 2022 - jacc.org
Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

CCS/CHFS heart failure guidelines update: defining a new pharmacologic standard of care for heart failure with reduced ejection fraction

M McDonald, S Virani, M Chan, A Ducharme… - Canadian Journal of …, 2021 - Elsevier
In this update of the Canadian Cardiovascular Society heart failure (HF) guidelines, we
provide comprehensive recommendations and practical tips for the pharmacologic …

[PDF][PDF] SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?

GM Kuster, O Pfister, T Burkard, Q Zhou… - European heart …, 2020 - academic.oup.com
OP-EHEA200234_online 1801..1803 Page 1 ..............................................................................
SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with …

Heart failure drug treatment—inertia, titration, and discontinuation: a multinational observational study (EVOLUTION HF)

G Savarese, T Kishi, O Vardeny, S Adamsson Eryd… - Heart Failure, 2023 - jacc.org
Background Guidelines recommend early initiation of multiple guideline-directed medical
therapies (GDMTs) to reduce mortality/rehospitalization in patients with heart failure and …

Risks and impact of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers on SARS-CoV-2 infection in adults: a living systematic review

K Mackey, VJ King, S Gurley, M Kiefer… - Annals of internal …, 2020 - acpjournals.org
An update is available for this article. Background: The role of angiotensin-converting
enzyme inhibitors (ACEIs) and angiotensin-receptor blockers (ARBs) in coronavirus disease …

2022 ACC/AHA/HFSA guideline for the management of heart failure

PA Heidenreich, B Bozkurt, D Aguilar, LA Allen… - Journal of Cardiac …, 2022 - Elsevier
ABSTRACT Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Pre‐discharge and early post‐discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC

M Metra, M Adamo, D Tomasoni… - European Journal of …, 2023 - Wiley Online Library
Acute heart failure is a major cause of urgent hospitalizations. These are followed by marked
increases in death and rehospitalization rates, which then decline exponentially though they …

Initiation, continuation, switching, and withdrawal of heart failure medical therapies during hospitalization

AA Bhagat, SJ Greene, M Vaduganathan… - JACC: Heart Failure, 2019 - jacc.org
Patients with worsening heart failure with reduced ejection fraction (HFrEF) spend a large
proportion of time in the hospital and other health care facilities. The benefits of guideline …

Physicians' guideline adherence is associated with long‐term heart failure mortality in outpatients with heart failure with reduced ejection fraction: the QUALIFY …

M Komajda, J Schöpe, S Wagenpfeil… - European Journal of …, 2019 - Wiley Online Library
Background Physicians' adherence to guideline‐recommended therapy is associated with
short‐term clinical outcomes in heart failure (HF) with reduced ejection fraction (HFrEF) …

Heart failure hospitalization and guideline-directed prescribing patterns among heart failure with reduced ejection fraction patients

PK Srivastava, AD DeVore, AS Hellkamp, L Thomas… - Heart Failure, 2021 - jacc.org
Objectives The authors sought to evaluate the association of heart failure hospitalization
(HFH) with guideline-directed medical therapy (GDMT) prescribing patterns among patients …